Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-025856
Filing Date
2022-10-03
Accepted
2022-10-03 16:21:32
Documents
1
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166482847172975.html 4  
1 FORM 4 wf-form4_166482847172975.xml 4 3881
  Complete submission text file 0001628280-22-025856.txt   5346
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 E. PRATT STREET SUITE 606 BALTIMORE MD 21202
Business Address
Persson Magnus (Reporting) CIK: 0001653222 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 221287744